169 related articles for article (PubMed ID: 12470219)
1. Subcellular detection and localization of the drug transporter P-glycoprotein in cultured tumor cells.
Molinari A; Calcabrini A; Meschini S; Stringaro A; Crateri P; Toccacieli L; Marra M; Colone M; Cianfriglia M; Arancia G
Curr Protein Pept Sci; 2002 Dec; 3(6):653-70. PubMed ID: 12470219
[TBL] [Abstract][Full Text] [Related]
2. Intracellular P-glycoprotein in multidrug resistant tumor cells.
Arancia G; Molinari A; Calcabrini A; Meschini S; Cianfriglia M
Ital J Anat Embryol; 2001; 106(2 Suppl 1):59-68. PubMed ID: 11729998
[TBL] [Abstract][Full Text] [Related]
3. Detection of P-glycoprotein in the nuclear envelope of multidrug resistant cells.
Calcabrini A; Meschini S; Stringaro A; Cianfriglia M; Arancia G; Molinari A
Histochem J; 2000 Oct; 32(10):599-606. PubMed ID: 11202156
[TBL] [Abstract][Full Text] [Related]
4. Multidrug resistance-associated protein: a protein distinct from P-glycoprotein involved in cytotoxic drug expulsion.
Barrand MA; Bagrij T; Neo SY
Gen Pharmacol; 1997 May; 28(5):639-45. PubMed ID: 9184795
[TBL] [Abstract][Full Text] [Related]
5. Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein.
Sikic BI; Fisher GA; Lum BL; Halsey J; Beketic-Oreskovic L; Chen G
Cancer Chemother Pharmacol; 1997; 40 Suppl():S13-9. PubMed ID: 9272128
[TBL] [Abstract][Full Text] [Related]
6. P-glycoprotein mediates drug resistance via a novel mechanism involving lysosomal sequestration.
Yamagishi T; Sahni S; Sharp DM; Arvind A; Jansson PJ; Richardson DR
J Biol Chem; 2013 Nov; 288(44):31761-71. PubMed ID: 24062304
[TBL] [Abstract][Full Text] [Related]
7. Role of the vacuolar H+-ATPase in daunorubicin distribution in etoposide-resistant MCF7 cells overexpressing the multidrug-resistance associated protein.
Benderra Z; Morjani H; Trussardi A; Manfait M
Int J Oncol; 1998 Mar; 12(3):711-5. PubMed ID: 9472114
[TBL] [Abstract][Full Text] [Related]
8. The multidrug transporter P-glycoprotein: a mediator of melanoma invasion?
Colone M; Calcabrini A; Toccacieli L; Bozzuto G; Stringaro A; Gentile M; Cianfriglia M; Ciervo A; Caraglia M; Budillon A; Meo G; Arancia G; Molinari A
J Invest Dermatol; 2008 Apr; 128(4):957-71. PubMed ID: 17943188
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic effect of the cyclosporin PSC 833 in multidrug-resistant leukaemia cells with increased expression of P-glycoprotein.
Lehne G; Rugstad HE
Br J Cancer; 1998 Sep; 78(5):593-600. PubMed ID: 9744497
[TBL] [Abstract][Full Text] [Related]
10. Non-P-glycoprotein multidrug resistance in cell lines which are defective in the cellular accumulation of drug.
Center MS
Cytotechnology; 1993; 12(1-3):109-25. PubMed ID: 7765322
[TBL] [Abstract][Full Text] [Related]
11. Detection of P-glycoprotein in the Golgi apparatus of drug-untreated human melanoma cells.
Molinari A; Calcabrini A; Meschini S; Stringaro A; Del Bufalo D; Cianfriglia M; Arancia G
Int J Cancer; 1998 Mar; 75(6):885-93. PubMed ID: 9506534
[TBL] [Abstract][Full Text] [Related]
12. Early multidrug resistance, defined by changes in intracellular doxorubicin distribution, independent of P-glycoprotein.
Schuurhuis GJ; Broxterman HJ; de Lange JH; Pinedo HM; van Heijningen TH; Kuiper CM; Scheffer GL; Scheper RJ; van Kalken CK; Baak JP
Br J Cancer; 1991 Nov; 64(5):857-61. PubMed ID: 1681887
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms of multidrug resistance in cancer chemotherapy.
Nooter K; Stoter G
Pathol Res Pract; 1996 Jul; 192(7):768-80. PubMed ID: 8880878
[TBL] [Abstract][Full Text] [Related]
14. Probing daunorubicin accumulation defects in non-P-glycoprotein expressing multidrug-resistant cell lines using digitonin.
Versantvoort CH; Broxterman HJ; Feller N; Dekker H; Kuiper CM; Lankelma J
Int J Cancer; 1992 Apr; 50(6):906-11. PubMed ID: 1348241
[TBL] [Abstract][Full Text] [Related]
15. Increase of P-glycoprotein-mediated drug resistance by hsp 90 beta.
Bertram J; Palfner K; Hiddemann W; Kneba M
Anticancer Drugs; 1996 Nov; 7(8):838-45. PubMed ID: 8991187
[TBL] [Abstract][Full Text] [Related]
16. Multidrug resistance: molecular mechanisms and clinical relevance.
Ling V
Cancer Chemother Pharmacol; 1997; 40 Suppl():S3-8. PubMed ID: 9272126
[TBL] [Abstract][Full Text] [Related]
17. Comparison of mechanisms responsible for resistance to idarubicin and daunorubicin in multidrug resistant LoVo cell lines.
Toffoli G; Simone F; Gigante M; Boiocchi M
Biochem Pharmacol; 1994 Nov; 48(10):1871-81. PubMed ID: 7986198
[TBL] [Abstract][Full Text] [Related]
18. Vinflunine (20',20'-difluoro-3',4'-dihydrovinorelbine), a novel Vinca alkaloid, which participates in P-glycoprotein (Pgp)-mediated multidrug resistance in vivo and in vitro.
Etievant C; Barret JM; Kruczynski A; Perrin D; Hill BT
Invest New Drugs; 1998; 16(1):3-17. PubMed ID: 9740539
[TBL] [Abstract][Full Text] [Related]
19. Differential cytotoxic effects of docetaxel in a range of mammalian tumor cell lines and certain drug resistant sublines in vitro.
Hill BT; Whelan RD; Shellard SA; McClean S; Hosking LK
Invest New Drugs; 1994; 12(3):169-82. PubMed ID: 7896535
[TBL] [Abstract][Full Text] [Related]
20. Glucose Modulation Induces Lysosome Formation and Increases Lysosomotropic Drug Sequestration via the P-Glycoprotein Drug Transporter.
Seebacher NA; Lane DJ; Jansson PJ; Richardson DR
J Biol Chem; 2016 Feb; 291(8):3796-820. PubMed ID: 26601947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]